Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
NCT04140526
Adenocarcinoma, Adenoid Cystic Carcinoma
Springdale, Arkansas, United States
View Trial DetailsNCT Number: NCT05708703
A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry the smartphone for 28 consecutive days while outside the home; keep smartphone location and motion services active; confirm and correct (if needed) smartphone-detected activities and trips; use the app interface to provide additional information on activities and trips related to cancer treatment tasks; complete daily surveys regarding well-being; and at the end of the 28 day period, complete an online survey.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
University of Alabama, Birmingham, Alabama, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 28 days
Summary of mobile app smartphone collected data from daily surveys about time spent at home on cancer-related care tasks over 28 days, including taking medications, scheduling appointments, handling medical bills, managing symptoms, monitoring health status and arranging help/transportation.
Time frame: 28 days
Summary of mobile app smartphone collected data from daily trips and surveys about time spent at home on cancer-related care tasks over 28 days, including out-of-home healthcare encounters, travel time, and at-home tasks including taking medications, scheduling appointments, handling medical bills, managing symptoms, monitoring health status and arranging help/transportation.
Time frame: 28 days
Summary of mobile app smartphone collected from daily-recorded trips away from home, collected over 28 days, focusing on those denoted as being related to cancer care (e.g. clinic visit, treatment, lab, pharmacy, imaging).
Masonic Cancer Center, University of Minnesota
Other
Time Toxicity of Cancer: the Time Demands of Cancer-related Activities and Their Impact on Well-being and Quality of Life
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04140526
Adenocarcinoma, Adenoid Cystic Carcinoma
Springdale, Arkansas, United States
View Trial DetailsNCT05796973
Adenocarcinoma, Adnexal Diseases
Tampere, Länsi-Suomi, Finland
View Trial DetailsNCT05567601
AIDS-Related Kaposi Sarcoma, AIDS-related Kaposi sarcoma
Vijayawada, Andhra Pradesh, India
View Trial DetailsNCT05349227
Adnexal Diseases, Behavior
Gainesville, Florida, United States
View Trial Details